Home » Newsletters » BioWorld Science

BioWorld Science

April 16, 2012

View Archived Issues

Roche divulges new tyrosine-protein kinase JAK inhibitors

Novel aptamer oligonucleotides designed in Italy

Bayer Schering discovers novel vasopressin receptor ligands

New CYPXVII inhibitors synthesized at Novartis

Purdue Pharma patents new sodium channel antagonists

Recombinant heat shock protein reduces atherogenesis in preclinical tests

AstraZeneca launches once-daily antihypertensive in U.S.

Exelixis reports novel PI3K-delta inhibitors

Novel GlyT1 inhibitors developed in Japan

Merck & Co. presents novel PDK1 inhibitors

New melanin-concentrating hormone receptor antagonists identified

New candidate cancer therapies under development at AstraZeneca

New cancer immunotherapy targets ALK-1 and VEGF pathways

GSK AMPK activators are active in diabetes and obesity models

Antimitotic cancer therapy shows promise in vivo and in vitro

Korean FDA clears phase II trial of ViroMed pain medicine

Gliolan gets Australian orphan drug status

Phase I/II ProSavin trial meets primary endpoint

AbGenomics presents antibody conjugates with anticancer activity

Eisai launches new formulation of rufinamide in U.K.

Novel Astellas histone deacetylase inhibitor has encouraging pharmacokinetics

Quantum Genomics launches first clinical study of its lead antihypertensive drug

GW confirms milestone payment from Almirall

Biodel selects ultrarapid-acting insulin formulation to advance to phase II testing

Piramal Imaging acquires PET tracers from Bayer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...